Sai Life Sciences Q2 FY27 Results: Consolidated Net Profit ₹98.32 Crore on Total Income of ₹663 Crore
- Earnings
- Contract research and manufacturing services
Reviewed byKeshav SehgalBlacklitt Research
Sai Life Sciences (NSE: SAILIFE) reported consolidated total income of ₹662.55 crore and net profit of ₹98.32 crore for the quarter ended 30 Sep 2026, it said in a filing on 05 Nov 2026. Standalone total income was ₹650.92 crore and net profit ₹96.01 crore for the same quarter.
Key highlights
Consolidated
Including its subsidiaries
- Total income: ₹662.55 crore, up 19.9% YoY and 18.8% QoQ
- Net profit: ₹98.32 crore, up 17.3% YoY and 34.2% QoQ
- EPS: Basic ₹4.63, against ₹4.01 a year earlier
- Finance costs: ₹10.94 crore, up 17.0% YoY
Standalone
The company on its own, without its subsidiaries
- Total income: ₹650.92 crore, up 20.2% YoY and 18.3% QoQ
- Net profit: ₹96.01 crore, up 15.7% YoY and 34.6% QoQ
- EPS: Basic ₹4.52, against ₹3.97 a year earlier
- Finance costs: ₹9.33 crore, up 21.2% YoY
Summary
| Particulars | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| 662.55 | 552.79 | +19.9% | 557.83 | +18.8% | |
| Revenue from operations | 658.59 | 537.47 | +22.5% | 554.29 | +18.8% |
| Other income | 3.97 | 15.33 | -74.1% | 3.54 | +12.0% |
| 98.32 | 83.84 | +17.3% | 73.29 | +34.2% | |
| Profit before tax | 131.28 | 112.05 | +17.2% | 97.97 | +34.0% |
| Finance costs | 10.94 | 9.35 | +17.0% | 7.64 | +43.3% |
| Depreciation | 48.13 | 39.75 | +21.1% | 45.94 | +4.8% |
| Tax expense | 32.96 | 28.21 | +16.9% | 24.69 | +33.5% |
| Net profit margin | 14.84% | 15.17% | -0.33 pp | 13.14% | +1.70 pp |
| EPS, basic (₹) | 4.63 | 4.01 | +15.5% | 3.46 | +33.8% |
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Revenue from operations rose 22.5% YoY to ₹658.59 crore, while other income fell 74.1% to ₹3.97 crore, so other income is now 0.6% of total income.
Net profit grew more slowly than total income year on year, up 17.3% against 19.9%. Finance costs of ₹10.94 crore, up 17.0%, and depreciation of ₹48.13 crore, up 21.1%, rose alongside income. Tax of ₹32.96 crore is 25.1% of profit before tax of ₹131.28 crore.
Against the June quarter, net profit rose 34.2%, faster than income at 18.8%. The filing does not give the reason for the quarter-on-quarter change in profit.
| Particulars | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| 650.92 | 541.60 | +20.2% | 550.27 | +18.3% | |
| Revenue from operations | 647.08 | 526.67 | +22.9% | 546.73 | +18.4% |
| Other income | 3.84 | 14.93 | -74.3% | 3.54 | +8.3% |
| 96.01 | 82.95 | +15.7% | 71.34 | +34.6% | |
| Profit before tax | 128.31 | 110.87 | +15.7% | 95.33 | +34.6% |
| Finance costs | 9.33 | 7.70 | +21.2% | 5.98 | +56.0% |
| Depreciation | 44.40 | 36.21 | +22.6% | 42.13 | +5.4% |
| Tax expense | 32.30 | 27.92 | +15.7% | 24.00 | +34.6% |
| Net profit margin | 14.75% | 15.32% | -0.57 pp | 12.96% | +1.79 pp |
| EPS, basic (₹) | 4.52 | 3.97 | +13.9% | 3.36 | +34.5% |
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
The standalone pattern matches the consolidated one. Revenue from operations rose 22.9% YoY to ₹647.08 crore, while other income fell 74.3% to ₹3.84 crore.
Standalone net profit of ₹96.01 crore is ₹2.31 crore below the consolidated figure. Net profit rose 15.7% YoY, in line with profit before tax, and finance costs rose 21.2% to ₹9.33 crore, faster than the group's 17.0%.
It does not appear in the quarter columns. The company says it will account for any further differential impact of the Labour Codes in later periods.
The company operates in one segment, Contract Research, Development and Manufacturing Services (CRDMO). Deloitte Haskins & Sells LLP issued an unmodified conclusion on the limited review of both sets of results. The auditor did not review two subsidiaries whose revenue was ₹38.49 crore in the quarter; other auditors reviewed them.
Inference
The filing reports 1,32,200 equity shares allotted in the quarter ended 30 Sep 2026 and 1,08,005 shares allotted on 05 Nov 2026, both on exercise of employee stock options. Consolidated net profit of ₹98.32 crore is not stated as a per-share dividend, and the filing gives no dividend for the period.
The board approved the appointment of Sidhartha Das, Vijay Kumar Suthari and Sriram Gopalakrishnan as Senior Management Personnel with effect from 05 Nov 2026. The filing does not say who they replace or why the roles were created.
Filed with BSE on . Reference: Original filing (PDF)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
